$PLPL Signs Agreement to Become Exclusive Supplier to USN

USN (www.usn.co.za) was founded in South Africa in 2000, and it remains a comprehensive health and nutrition supplement brand, driving the forefront of sports nutrition globally. Rapid expansion and an increasing consumer base have been realized through a commitment to leading product innovation, the highest quality raw material suppliers globally, premium manufacturing facilities and excellent customer support on all levels. All products are formulated with the backing of extensive research and scientific findings, as well as the important clinical trials to ensure efficacy and safety. USN continues its global growth strategy, and it is now being sold in pharmacies, FMCG and specialist retailers in over 53 countries on four continents.

This agreement also allows USN to further control the input costs around production, while enhancing product efficacy by replacing the generic green tea extracts in its extensive stable of innovative and market leading products, with the clinically proven highly bioavailable Phytofare® catechin complex. This agreement gives Plandai the opportunity to cement its relationship with a long-term global customer who has a vision for growth and market expansion.

Callum Baylis-Duffield, Vice President of Sales and Marketing for Plandaí, commented, “We are extremely pleased to enter into this agreement with a company that has the remarkable reputation of USN. As a leader in sports nutrition, they understand the benefits of phyto-availability within their product line-up, as well as the need to ensure that customers are getting the maximum potential and benefit from their supplements. Such a brand can only continue its innovative streak and fantastic track record.”

Irma Botes, Head of Research and Development at USN, added, “Establishing long-term relationships with a supplier like Plandaí is an important part of ensuring that we remain at the forefront of our industry. Customers are demanding more and more from their bodies and from their nutrition supplement partner, and USN remains committed to providing the best products to the global market place. Phytofare®, by focusing on both absorption and residence in the body, using all natural botanicals, gives us a huge competitive advantage — an advantage we’re confident our customers will notice in their performance and overall health.”

USN Founder and CEO, Albe Geldenhuys commented, “Our industry is continually progressing with respect to product innovation and scientific findings. Establishing long-term relationships with leading suppliers globally ensures that our brand embraces the innovation and the science that drives this industry, cementing our position as a global leader. This agreement is a commitment to a mutual investment that will see further product improvements in our offering this year and well into the future.”

About Plandaí Biotechnology, Inc.

Plandaí Biotechnology, Inc. and its subsidiaries develop highly phyto-available extracts. Plandaí Biotechnology controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing its proprietary Phytofare^™ extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company’s products include beverage, cosmeceutical, wellness, nutriceutical, anti-aging, and pharmaceutical. For more information, please visithttps://www.plandaibiotech.com.

Safe Harbor Statement

This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like “may,” “will,” “should,” “could,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project” or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Readers are advised to review our filings with the Securities and Exchange Commission that can be accessed over the Internet at the SEC’s website located at https://www.sec.gov.